➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Merck
McKesson
Dow
Medtronic

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: irinotecan hydrochloride


Email this page to a colleague

« Back to Dashboard

IRINOTECAN

CASRN: 97682-44-5

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Mallinckrodt
Dow
Moodys
Colorcon